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A new method using comprehensive two-dimensional gas chromatography and 
isotope dilution time-of-flight mass spectrometry (GCxGC-IDTOFMS) for the 
simultaneous measurement of selected polychlorinated biphenyls (PCBs), 
organochlorine pesticides (OCPs), and brominated flame retardants (BFRs) is 
presented. Conversely to reference methods based on classical GC-MS, a single 
injection of the extract containing all species of interest conducts to accurate 
identification and quantification. GCxGC ensures the chromatographic separation of 
most compounds and TOFMS allows mass spectral deconvolution of co-eluting 
compounds as well as the use of 
13
C-labeled internal standards for quantification. 
Isotope ratio measurements of the most intense ions for both natives and labels ensure 
the required specificity. Potentially interfering matrix compounds are usually kept 
away from the compounds to be measured in the chromatographic space. The use of 
this new method with automated sample preparation procedures developed at the 
Centers for Disease Control and Prevention (CDC) for the analysis of human serum 
and milk [1,2] compared favorably to conventional isotope-dilution one-dimensional 
gas chromatography-high resolution mass spectrometry (GC-IDHRMS) for the 
different sample pools that were tested 
 
EXPERIMENTAL 
Standards, Chemicals and Supplies. All standard solutions were purchased from 
Cambridge Isotope Laboratories (Andover, MS, USA). The EC-5022 PCB 10-points 
calibration standard solution contained a mixture of 38 native PCBs: IUPAC no. 18, 
28, 44, 49, 52, 66, 74, 87, 99, 101, 105, 110, 118, 128, 138, 146, 149, 151, 153, 156, 
157, 158, 167, 170, 172, 177, 178, 180, 183, 187, 189, 194, 195, 196, 201, 203, 206, 
209 spanning the concentration range 0.5 to 1000 pg/µL; as well as 
13
C12-labeled 
PCBs at a concentration of 75 pg/µL in nonane. The EC-5087 
13
C12-labeled PCB 
internal standard spiking solution contained 
13
C12-labeled PCBs at a concentration of 
7.5 pg/µL in methanol. The EO-5159 BFR 10-points calibration standard solution 
contained a mixture of native, spanning the concentration range 0.2 to 2000 pg/µL, 
and 
13
C12-labeled analytes, at a concentration of 75 pg/µL. The solution contained the 
following PBDEs: IUPAC no. 17, 28, 47, 66, 85, 99, 100, 153, 154, 183, 203, 209, as 
well as CB-153 and the polybrominated biphenyl BB-153. The EO-5158 
13
C12-labeled 
BFR internal standard spiking solution 
13
C12-labeled compounds at a concentration of 
7.5 pg/µL in methanol. The ES-5019 persistent OCP 8-points calibration standard 
solution contained the following mixture of native and 
13
C-labeled analytes: HCB, β-
HCCH, γ-HCCH, heptachlor epoxide, oxychlordane, trans-nonachlor, dieldrin, o,p’-
DDT, p,p’-DDT, mirex, p,p’-DDE. Natives were in the concentration range of 5 to 
1000 pg/µL, and 
13
Cn-labeled at a concentration of 100 or 250 pg/µL. The ES-5177 
13
Cn- labeled OCP internal standard spiking solution contained (10 pg/µL in 
methanol) was used. We prepared the multi-analyte calibration solution (59 native 
compounds) by combining equal volumes of the EC-5022, EO-5159, and ES-5019 
solutions and reducing the final volume. All details concerning consumables, as well 
as the glassware pre-cleaning are available elsewere [1,2]. 
Samples. Human serum samples corresponded to a pool collected from 15 individuals 
in 2002 in 3 U.S. cities (Philadelphia, PA; Memphis, TN; Miami, FL) and obtained 
from the Menphis, TN Interstate blood bank. A mixture of water (3.5 mL) and calf 
serum (0.5 mL) (Bibco BRL; Grand Island, NY) was used as serum blank. Three 
human milk pools were analyzed. Pool A was obtained from the Mothers’ milk bank 
(Denver, CO) and was a composite pool of 2 individuals collected in 2002, pool B 
and C both corresponded to 10 specimens collected in 2003 in California and in 
North-Carolina, respectively. A 10-fold water diluted bovine milk obtained in a local 
supermarket was used as method blank samples. 
Extraction and Cleanup. A semi-automated extraction and cleanup method has 
recently been developed for the measurement of the PCBs, OCPs, and BFRs in human 
serum and milk and is described in details elsewere [1-3]. Briefly, serum pre-
treatment was carried out using the Gilson 215 liquid handler (Gilson, Middleton, 
WI). Solid phase extraction and cleanup were performed on a Zymark Rapidtrace 
Automated SPE workstation (Zymark Corp., Hopkinton, MA). Custom made Oasis 
HLB SPE cartridges (3 mL, 540mg) (Waters Corp., Milford, MA) were used for 
extraction of 4 mL serum samples. Removal of co-extracted biogenic materials was 
performed on a two layered custom made SPE cartridge (3 mL) packed with 100 mg 
silica and 1000 mg sulfuric acid silica. All extracts were evaporated using a Labconco 
Rapidvap evaporator (Labconco Corp., Kansas City, MO) and transferred to GC-vials 
prior GC-MS analyzes. Nonane was used as a keeper. QA/QC criteria, reproducibility 
and precision data, as well as details on the serum enzymatic lipid determinations are 
available in a previous report [1]. For human milk samples, the extraction step was 
performed on 1 g of milk by matrix solid phase dispersion using diatomaceous earth 
(3 mL cartridges, 900 mg) [2]. The amount of extracted lipids was determined 
gravimetrically on analytical balance. The same protocol as for serum was used for 
the remaining cleanup of human milk samples. 
GC-IDHRMS analysis. They were performed on a MAT95XP instrument 
(ThermoFinnigan MAT, Bremen, Germany) interfaced with a 6890N gas 
chromatograph (Agilent Technologies, Atlanta, GA) fitted with a 15 m x 0.25 mm i.d. 
x 0.10 µm film thickness DB-5HT capillary column (J&W Scientific, Folsom, CA). 
Splitless injections were carried out with an injector temperature of 280
o
C. The oven 
was programmed from 140
o
C (1 min) to 320
o
C with a ramp rate of 10
o
C/min. The 
source temperature was 280
o
C in the electron impact mode using a filament bias of 40 
eV. Details of the GC-IDHRMS analyses are given elsewhere [1]. 
GCxGC-IDTOFMS analysis. The GCxGC-TOFMS instrument was the Pegasus 4D 
(Leco Corp., St Joseph, MI). This system was based on a non-moving quadruple jet 
dual stage modulator made of two cold nitrogen jets and two pulsed hot air jets 
responsible for trapping and refocusing of compounds eluting from the 
1
D column. 
This modulator was mounted in an Agilent 6890 GC oven and liquid nitrogen was 
used to create the cold jets. Details regarding the system have been reported elsewhere 
[4,5]. The automated 1.2 µL injections were performed using a MultiPurposeSampler 
MPS2 (Gerstel Inc., Baltimore, MD). The GC inlet temperature was 280°C for 
splitless injections. The purge time was 120 s at a flow of 20 mL/min. Carrier gas was 
helium and a constant flow of 0.8 mL/min was used. The GC column set used was 
made of the combination of a 15 m x 0.25 mm i.d. DB-1 100% dimethylpolysiloxane 
(J&W Scientific) with a film thickness of 0.25 µm as 
1
D and a 1.2 m x 0.10 mm i.d. 
high temperature HT-8 (8% Phenyl)-polycarborane-siloxane (SGE, Austin, TX) with 
a film thickness of 0.10 µm as 
2
D. Deactivated universal presstight connectors (Restek 
Corp., Bellefonte, PA) were used for connecting the capillary columns. Leak-free 
connections were ensured by careful inspection of the column cuts and cleanup of the 
column ends using acetone in order to remove any finger grease and soften the silica 
prior sealing. The connection was cured from 40°C to 320°C at a temperature ramp 
rate of 2°C/min and held at the final temperature for 2 hours. During chromatographic 
separation, the primary GC oven was programmed as follows: 90°C for 1 min, then to 
150°C at 10°C/min, and finally to 300°C at 1°C/min. The 
2
D column was coiled into 
the secondary oven that was 40°C higher than the primary oven and operated in the 
iso-ramping mode. The temperature of the modulator had an offset of 60°C compared 
to the temperature of the primary GC oven. Modulation was carried out on the very 
beginning of the 
2
D column. The modulator period was 3 s (0.33 Hz modulation 
frequency) with a hot pulse duration set at 700 ms and a cool time between stages of 
800 ms. 
The transfer line connecting the secondary column and the MS source was operated at 
a temperature of 250°C. The source temperature was 250°C with a filament bias 
voltage of -70 V. The unit m/z resolution mass spectrometer was capable of acquiring 
5000 transients/s, which results in 500 summed complete mass spectra/s for the mass 
range from 10 to 1000 m/z. The data acquisition rate was set at 60 spectra/s for a 
collected mass range ranging from 100 to 750 m/z. Table 1 lists the masses selected 
for quantification. 
The detector voltage was 1800 V. Data collection and processing were achieved using 
the 2.10 version of Leco ChromaTOF
TM
 software provided with the instrument. Peak 
apex finding was performed automatically and further manually corrected when 
required. The combination of slices corresponding to a compound was performed by 
automatically comparing the mass spectra under pre-established match criteria. 
Spectral searching was performed using the NIST library available with the software, 
as well as through the custom built 
13
C-labeled compound library. 
 
RESULTS AND DISCUSSION 
The last compound (BDE-154) eluted after 45 min (analytical speed of 1.3 analytes 
/min). Most of the compounds were chromatographically resolved from each other. 
Heptachlor epoxide and Tetra-CB-74, as well as Hepta-CB-189 and Octa-CB-196 
were two co-eluting couples that required the use of the deconvolution capability to 
be resolved. Figure 1 shows chromatograms of a multi-analyte standard solution and a 
real sample extract. The calibration curve covered 3 orders of magnitude with 
instrument LODs of 1 pg/µL injected (S/N>3 for the base peak). An example of 
quantification is shown in Figure 2 for Mirex and hepta-CB-170. It appeared to be 
important to carry out the quantification on the entire set of slices corresponding to 
one analyte. The ratio between corresponding native and 
13
C-label slices varies over 
the peak cluster. As illustrated in Table 2, the ratio between native and 
13
C-label was 
calculated after the summation of the area of all combined slices. 
 
Table 1. List of masses used to reconstruct deconvoluted ion currents (DICs) 
during the GCxGC-IDTOFMS quantification process 
Compounds
12
C-native ions (m/z )
13












β - and γ -HCCH 217+219+221+252+254+256+288+290+292 223+225+227+258+260+262+294+296+298
Heptachlor epoxide 351+353+355+357+388+390 361+363+365+367+398+400
Oxychlordane 385+387+389+391+422+424+426 395+397+399+401+432+434+436
trans -Nonachlor 407+409+411+413+442+444+446+448 417+419+421+423+452+454+456+458
Dieldrin 261+263+265+343+345+347+378+380+382 275+277+279+355+357+359+390+390+394
o,p'-  and p,p' -DDT 235+237+239 247+249+251
Mirex 235+237+239+241+270+272+274+276 240+242+244+246+275+277+279+281












Table 2. Variation in the native over 
13






tR (S) area S/N area S/N Ratio
a
BDE-99-1 2493 1.72 4755 22.00 786 4.00 0.17
BDE-99-2
b 2496 1.68 20523 102.00 4351 20.00 0.21
BDE-99-3
c 2499 1.71 18341 78.00 6335 26.00 0.35
BDE-99-4 2502 1.65 3940 21.00 2210 10.00 0.56
Sum - 47559 - 13682 - 0.29
a
























































Figure 1. Comprehensive two-dimensional gas chromatograms for a contour plot 
of TIC chromatogram of a 100 pg/µL native compound multi-analytes 








































































































Figure 2. Region of the chromatogram of a real human serum sample (top) 
where Mirex and CB-170 elute. Extracted ion chromatograms are 
based on ions listed in Table 1 for those 2 compounds (native and 
labeled). Peaks are: (1) Mirex, (2) CB-170, (3) phthlalate, (4) siloxane 
bleed, (5) tetracosane. The dashed Gaussian shapes are artificial and 
are only shown to help to locate the elution windows of the 2 
compounds. Expanded section (bottom) showing one of the slices 
illustrating chromatographic and mass spectral resolution of the 2 
compounds and their corresponding 
13
C labels (left) as well as the 
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Human serum QC samples were used to build up QC charts for both GC-IDHRMS 
and GCxGC-IDTOFMS methods for all investigated analytes. Figure 3 illustrates the 
case of DBE-47, DBE-100 and CB-153. The SD values are higher with GCxGC-
IDTOFMS partly because several slices of different intensities had to be integrated 
and also due to the low mass resolution of the TOFMS. Finally, OCP (Figure 4) and 
BDE (Table 3) data are shown for human serum and milk samples, respectively. 
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Figure 4. Comparison between GCxGC-IDTOFMS and the reference GC-




























































































































































































Table 3. Comparison between the new GCxGC-IDTOFMS and the reference 
GC-IDHRMS method for the measurement (ng/g lipids) of selected BDEs in 







Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
BDE-28 6.6 0.6 7.7 0.2 15.3 12.7 0.9 11.7 1.0 8.3 2.9 0.1 4.0 0.5 41.0
BDE-47 230.4 8.2 227.4 17.4 1.3 284.5 14.0 308.3 24.4 8.4 64.0 2.8 65.7 0.4 2.6
BDE-100 46.1 1.7 49.4 0.9 7.3 45.6 2.2 53.9 3.7 18.3 11.4 0.6 11.4 0.7 0.3
BDE-99 71.6 2.9 76.7 1.6 7.1 74.0 2.6 81.7 6.4 10.4 19.3 0.7 19.7 0.6 1.9
BB-153 0.7 0.1 1.0 0.3 52.7 1.2 0.0 1.6 0.5 27.7 6.7 0.4 9.0 0.7 33.6
BDE-154 5.9 0.2 4.9 0.4 17.3 3.7 0.2 4.7 1.1 27.3 1.1 0.0 0.9 0.2 18.3
BDE-85 7.9 1.0 6.1 0.3 22.9 6.9 0.2 7.4 0.8 7.1 1.6 0.0 - -
BDE-153 18.5 1.4 18.6 0.3 0.7 21.4 0.9 25.8 5.4 20.4 9.2 0.4 9.8 0.9 6.1
ΣBDEs 386.9 36.5 390.8 16.2 1.0 448.8 20.9 493.5 39.0 9.9 109.5 4.7 111.5 2.1 1.8
a 
SEM, standard error of the mean. 
b
 Deviation between the 2 methods. 
n=120 n=4n=3 n=4 n=3 n=4
Pool A Pool B Pool C
GC-HRMS GCxGC-TOFMS GC-HRMS GCxGC-TOFMS GC-HRMS GCxGC-TOFMS
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